A novel and accurate microfluidic assay of CD62L in bladder cancer serum samples-Reference-Cited by-同舟云学术

A novel and accurate microfluidic assay of CD62L in bladder cancer serum samples

Author:

Phadke Gayatri S.¹²³⁴^ORCID,Satterwhite-Warden Jennifer E.¹²³⁴,Choudhary Dharamainder⁵⁶⁷⁴,Taylor John A.⁸⁹¹⁰⁴^ORCID,Rusling James F.¹²³⁴⁵^ORCID

Affiliation:

1. Department of Chemistry (U-3060)

2. University of Connecticut

3. Storrs

4. USA

5. Department of Surgery

6. University of Connecticut Health Center

7. Farmington

8. Department of Urology

9. University of Kansas Medical Center

10. Kansas City

Abstract

A magnetic bead-based, microfluidic immunoarray of CD62L can distinguish between low- and high-grade bladder cancer tumors.

Funder

National Institute of Biomedical Imaging and Bioengineering

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

Reference41 articles.

1. American Cancer Society , Cancer facts and figures , American Cancer Society , Atlanta , 2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Biosensors in Bladder Cancer;Critical Reviews in Analytical Chemistry;2024-07-08